GlassScriptPhysician profile
Kyle Mckray Smith
NPI 1821653155
$72,483.53
in general payments reported to CMS, 2019-2025
32 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,356 · 2022: $9,424 · 2023: $5,546 · 2024: $37K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $26K · Consulting Fee: $25K · Food and Beverage: $8,383 · Education: $1,500 · Long Term Medical Supply Or Device Loan: $432 · Entertainment: $23.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $26,200.60 |
| Consulting Fee | $25,165.50 |
| Food and Beverage | $8,382.94 |
| Education | $1,500.00 |
| Long Term Medical Supply Or Device Loan | $431.56 |
| Entertainment | $23.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $30,651.22 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $23,622.17 | 2021-2025 | Truelok, Physio-Stim, Spinal-Stim |
| Stryker Corporation | $6,264.05 | 2022-2025 | Variax, Valor, Hoffmann |
| Rock Medical Orthopedics, INC. | $3,735.80 | 2022-2024 | |
| Access Pro Medical, LLC | $1,983.49 | 2025 | Matriderm |
| Vilex LLC | $1,983.06 | 2025 | Redemption |
| Arthrex, INC. | $1,929.43 | 2022-2024 | |
| Tulavi Therapeutics, INC. | $581.02 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Smith+Nephew, INC. | $484.51 | 2022-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Arteriocyte Medical Systems, INC. | $312.53 | 2022-2023 | Magellan |
| Kerecis Limited | $126.97 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $100.46 | 2023-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Medtronic, INC. | $94.69 | 2024 | In.Pact Admiral |
| Mimedx Group, INC. | $67.17 | 2024 | |
| Axogen | $64.45 | 2024-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $59.12 | 2022-2024 | Genex, Avitus Bone Harvester, Nextremity General Instrument |
| Bioventus LLC | $52.76 | 2022 | |
| Paragon 28, INC. | $49.32 | 2023 | Monkey Rings, Ttc Nail |
| Janssen Pharmaceuticals, INC | $34.96 | 2022 | |
| Paratek Pharmaceuticals, INC. | $33.02 | 2024 | Nuzyra |
| Kci USA, INC. | $29.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $29.27 | 2025 | Exparel |
| Exact Sciences Corporation | $26.33 | 2024 | Cologuard Collection Kit |
| Averitas Pharma INC. | $26.21 | 2024 | Qutenza |
| Argentum Medical | $23.10 | 2025 | |
| Avanos Medical | $20.91 | 2024 | On-Q* Pump and Accessories |
| Kowa Pharmaceuticals America, INC. | $20.62 | 2023 | Seglentis |
| Ani Pharmaceuticals, INC. | $18.29 | 2025 | Purified Cortrophin Gel |
| Depuy Synthes Sales INC. | $16.25 | 2025 | Hammerlock |
| Alafair Biosciences, INC. | $14.37 | 2024 | Versawrap |
| Amgen INC. | $14.34 | 2025 | Krystexxa |
| Acumed LLC | $14.00 | 2023 | Acumed, Innate Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.